Asubio Pharma Broadens Inclusion Criteria for Landmark Spinal Cord Injury

Asubio Pharma Broadens Inclusion Criteria for Landmark Spinal Cord Injury
Interested physicians or trauma/rehabilitation center representatives should contact Ben Levinson at [email protected] for more information regarding ASCENT-ASCI trial participation, or visit ClinicalTrials.gov (NCT01502631). "The recent adoption of …
Read more on Lifescience-online

Asubio Broadens Inclusion Criteria For Landmark Spinal Cord Injury Clinical Trial
PARAMUS, N.J., July 8, 2013 /PRNewswire/ — Asubio Pharmaceuticals, Inc. today announced the expansion of enrollment for its ASCENT-ASCI (Asubio Spinal Cord Early Neuro-recovery Treatment for Acute Spinal Cord Injury) trial to include AIS A, B and C …
Read more on Wall Street Journal

John Theurer Cancer Center at HackensackUMC Presents Governor Christie
“The John Theurer Cancer Center at HackensackUMC is one of the nation's top centers for cancer care and has provided extraordinary treatment to countless New Jersey residents living with cancer. I am honored to receive this award and accept it on …
Read more on ParamusPost.com